Pharmafile Logo
Pharmafocus logo
Advanced Search

resp

Showing 5 posts of 5 posts found.

Novartislr

Novartis’ COPD contender cleared in EU

December 4, 2009
Sales and Marketing COPD, Novartis, resp

 Novartis has been given a green light in the European Union to sell its Onbrez respiratory drug, allowing the firm …

News

GSK begins phase III COPD trials

October 28, 2009
Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory

GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …

News

MedImmune’s respiratory treatment faces US approval delay

December 3, 2008
Sales and Marketing US, reg, resp

One of MedImmune's key products has hit a delay in the US, after regulators demanded further data. The FDA asked …

News

Spiriva partners defend drug’s safety

October 2, 2008
Sales and Marketing Boehringer, COPD, Spiriva, resp

Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …

News

Boehringer Ingelheim outpaces market

April 14, 2008
Sales and Marketing resp

Strong growth in respiratory product Spiriva once again led the way for Boehringer Ingelheim, which has just published results for …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024